New PET tracer could spot hidden thyroid cancer

NCT ID NCT07436455

Recruiting now Diagnosis Sponsor: Ankara University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new imaging agent called F-18 TFB for PET/CT scans in people who have had surgery and radioactive iodine for differentiated thyroid cancer but still have high tumor markers. The goal is to see if F-18 TFB finds cancer lesions better than the standard FDG PET/CT scan. About 50 adults will participate, and results will be compared to biopsy or follow-up findings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFERENTIATED THYROID CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

differentiated thyroid carcinoma thyroid cancer Thyroid Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIFFERENTIATED THYROID CANCER THYROID CANCER

Contacts and locations

Locations

Ankara University Medical School Nuclear Medicine Department
RECRUITING

Ankara, Ankara, 06590, Turkey (Türkiye)
Hacettepe University Medical School Nuclear Medicine Department
RECRUITING

Ankara, Ankara, 06590, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.